Progress of the acyl-Coenzyme A thioester hydrolase family in cancer

Lu Bai1,2, Pengjie Yang3, Bater Han3

  • 1Inner Mongolia Medical University, Hohhot, China.

Frontiers in Oncology
|April 2, 2024
PubMed

Insights

The acyl-Coenzyme A thioester hydrolase (ACOTs) family regulates lipid metabolism by hydrolyzing fatty acyl-Coenzyme A. This review explores ACOTs

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The acyl-Coenzyme A thioester hydrolase (ACOTs) family are key enzymes in lipid metabolism, hydrolyzing fatty acyl-Coenzyme A to regulate free fatty acids and Coenzyme A levels.
  • ACOTs are divided into two structurally distinct superfamilies: type-I (α/β-hydrolase fold) and type-II ('hot dog' fold), with four and eight human genes, respectively.
  • Despite catalyzing the same reaction, these subgroups differ significantly in structure, sequence homology, and protein functions.

Purpose of the Study:

  • To review the classification and structural characteristics of the ACOTs family.
  • To summarize recent advances concerning ACOTs in digestive, respiratory, and urinary systemic tumors.
  • To identify potential drug targets and therapeutic strategies for tumor prevention and treatment.

Main Methods:

  • Literature review of ACOTs family classification and structure.
  • Analysis of ACOTs' role in various systemic tumors.
  • Exploration of ACOTs as potential therapeutic targets.

Main Results:

  • The review details the classification and structural diversity within the ACOTs family.
  • Advances in understanding ACOTs' involvement in digestive, respiratory, and urinary system tumors are presented.
  • The study highlights ACOTs' potential as specific drug targets for cancer intervention.

Conclusions:

  • The ACOTs family plays a critical role in lipid metabolism and is implicated in various systemic tumors.
  • Understanding ACOTs' structural and functional diversity is crucial for developing targeted cancer therapies.
  • Further research into ACOTs may yield novel strategies for tumor prevention and treatment.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.2K